Recognized as Place of research
28
Dec
Share
No Comments on A Human Monoclonal Antibody Blocking SARS-CoV-2 Infection Antibody, SARS-CoV-2
A Human Monoclonal Antibody Blocking SARS-CoV-2 Infection
The serious acute respiratory syndrome covid 2 is the etiological agent of the covid induced disease 19 that emerged in china in late 2019 and caused a global pandemic. SARS-CoV-2 belongs to the subgenus Sarbecovirus together with SARS-CoV that emerged in 2002[…]
Read More25
Jul
Share
No Comments on Challenges In The Development of Therapeutic Antibody Antibody
Challenges In The Development of Therapeutic Antibody
The progress in engineering and clinical development has been remarkable in the development of Therapeutic Antibody for 40 years, with the work done by Kohler and Milstein. The US FDA has led approval to the 21 antibodies for cancer immunotherapy. The approved[…]
Read More01
Oct
Share
No Comments on The Journey Of Antibody: From The Magic Bullet To Bedside Drug Monoclonal Antibodies
The Journey Of Antibody: From The Magic Bullet To Bedside Drug
All through three-generation, we have witnessed the wonderful use of Monoclonal antibody production in the way it helps in our diagnosis and therapy. Immunotherapy with a targeted molecule like Antibody has gained a lot of attention in cancer treatment due to its[…]
Read More
